[Recurrence risk in venous thromboembolic disease after anticoagulation discontinuation]
- PMID: 22995846
- DOI: 10.1016/j.medcli.2012.06.023
[Recurrence risk in venous thromboembolic disease after anticoagulation discontinuation]
Abstract
To determine the risk for recurrence of venous thromboembolic disease is essential to decide the optimum duration of treatment. Clinical risk factors, elevated D-dimer after anticoagulation withdrawal and the presence of residual deep vein thrombosis should be considered. In this article the risk factors and the reported risk models are reviewed.
Copyright © 2012 Elsevier España, S.L. All rights reserved.
Similar articles
-
Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.Thromb Haemost. 2015 Jun;113(6):1210-5. doi: 10.1160/TH14-04-0396. Epub 2014 Aug 14. Thromb Haemost. 2015. PMID: 25119194 Review.
-
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.Eur J Intern Med. 2014 Jan;25(1):25-30. doi: 10.1016/j.ejim.2013.09.005. Epub 2013 Oct 9. Eur J Intern Med. 2014. PMID: 24120221 Review.
-
Vascular Disease Patient Information Page: Cancer-associated thrombosis.Vasc Med. 2020 Jun;25(3):286-288. doi: 10.1177/1358863X20918311. Epub 2020 May 8. Vasc Med. 2020. PMID: 32384252 No abstract available.
-
Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs.Thromb Haemost. 2010 Dec;104(6):1083-4. doi: 10.1160/TH10-09-0584. Epub 2010 Sep 30. Thromb Haemost. 2010. PMID: 20886198 No abstract available.
-
Deep venous thrombosis and venous thromboembolism prophylaxis.Surg Clin North Am. 2015 Apr;95(2):285-300. doi: 10.1016/j.suc.2014.11.005. Surg Clin North Am. 2015. PMID: 25814107 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical